Marshall Wace’s Compugen CGEN Stock Holding History

Marshall Wace’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$521K	Buy	244,480 +138,176	+130%	+$268K	﹤0.01%	2431
2025 Q4	$163K	Buy	106,304 +61,202	+136%	+$102K	﹤0.01%	2635
2025 Q3	$66.3K	Buy	+45,102	New	+$67K	﹤0.01%	2700
2025 Q2	–	Sell	-40,489	Closed	-$59.1K	–	2748
2025 Q1	$59.1K	Sell	40,489 -47,680	-54%	-$93.1K	﹤0.01%	2525
2024 Q4	$135K	Buy	88,169 +40,494	+85%	+$65.8K	﹤0.01%	2411
2024 Q3	$86.3K	Buy	+47,675	New	+$87K	﹤0.01%	2391
2022 Q3	–	Sell	-13,415	Closed	-$25K	–	3382
2022 Q2	$25K	Buy	+13,415	New	+$29K	﹤0.01%	3354
2022 Q1	–	Sell	-561,335	Closed	-$2.41M	–	3406
2021 Q4	$2.41M	Buy	561,335 +544,853	+3,306%	+$2.95M	﹤0.01%	1925
2021 Q3	$100K	Sell	16,482 -80,387	-83%	-$538K	﹤0.01%	2890
2021 Q2	$802K	Buy	96,869 +56,484	+140%	+$459K	﹤0.01%	1918
2021 Q1	$339K	Buy	+40,385	New	+$448K	﹤0.01%	2087

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

Marshall Wace's CGEN Position: Q1 2026 in Review

Marshall Wace increased its Compugen (CGEN) stake by 130% in Q1 2026, buying an estimated $268K and bringing the position to 244,480 shares worth $521K. The position accounts for ﹤0.01% of the portfolio, ranked #2431.

Marshall Wace first reported a position in CGEN in Q1 2021 and has held it in 11 quarters since. The position peaked at $2.41M in Q4 2021. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

Marshall Wace held 244,480 shares of Compugen worth $521K as of Q1 2026.
Marshall Wace bought 138,176 Compugen shares in Q1 2026, an estimated $268K.
Compugen made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2431 holding.
Marshall Wace first reported a position in Compugen in Q1 2021 and has held it in 11 quarters since.
Marshall Wace's Compugen position peaked at $2.41M in Q4 2021.
78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.